ArticleCancer chemotherapy and pharmacology2018

Exposure-response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer.

Seiichi Hayato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.